TG Therapeutics Inc logo

TG Therapeutics Inc

FRA:NKB2 (USA)   Ordinary Shares
€ 15.49 (+1.22%) Jun 19
76.23
P/B:
16.19
Market Cap:
€ 2.41B ($ 2.59B)
Enterprise V:
€ 2.32B ($ 2.49B)
Volume:
-
Avg Vol (2M):
159.00
Trade In:

TG Therapeutics Inc Valuation Measures